142 related articles for article (PubMed ID: 11099478)
1. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5.
Zhang JC; Claffey K; Sakthivel R; Darzynkiewicz Z; Shaw DE; Leal J; Wang YC; Lu FM; McCrae KR
FASEB J; 2000 Dec; 14(15):2589-600. PubMed ID: 11099478
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis by two-chain high molecular weight kininogen (HKa) and kininogen-derived polypeptides.
Zhang JC; Qi X; Juarez J; Plunkett M; Donaté F; Sakthivel R; Mazar AP; McCrae KR
Can J Physiol Pharmacol; 2002 Feb; 80(2):85-90. PubMed ID: 11934260
[TBL] [Abstract][Full Text] [Related]
3. The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin.
Zhang JC; Donate F; Qi X; Ziats NP; Juarez JC; Mazar AP; Pang YP; McCrae KR
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12224-9. PubMed ID: 12196635
[TBL] [Abstract][Full Text] [Related]
4. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis.
Colman RW; Jameson BA; Lin Y; Johnson D; Mousa SA
Blood; 2000 Jan; 95(2):543-50. PubMed ID: 10627460
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5.
McCrae KR; Doñate F; Merkulov S; Sun D; Qi X; Shaw DE
Curr Cancer Drug Targets; 2005 Nov; 5(7):519-28. PubMed ID: 16305348
[TBL] [Abstract][Full Text] [Related]
6. Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through Akt.
Katkade V; Soyombo AA; Isordia-Salas I; Bradford HN; Gaughan JP; Colman RW; Panetti TS
Thromb Haemost; 2005 Sep; 94(3):606-14. PubMed ID: 16268479
[TBL] [Abstract][Full Text] [Related]
7. Kininostatin as an antiangiogenic inhibitor: what we know and what we do not know.
Guo YL; Wang S; Colman RW
Int Immunopharmacol; 2002 Dec; 2(13-14):1931-40. PubMed ID: 12489806
[TBL] [Abstract][Full Text] [Related]
8. Endothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species.
Sun D; McCrae KR
Blood; 2006 Jun; 107(12):4714-20. PubMed ID: 16418331
[TBL] [Abstract][Full Text] [Related]
9. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen.
Chavakis T; Kanse SM; Pixley RA; May AE; Isordia-Salas I; Colman RW; Preissner KT
FASEB J; 2001 Nov; 15(13):2365-76. PubMed ID: 11689462
[TBL] [Abstract][Full Text] [Related]
10. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis by antibody blocking the action of proangiogenic high-molecular-weight kininogen.
Colman RW; Pixley RA; Sainz IM; Song JS; Isordia-Salas I; Muhamed SN; Powell JA; Mousa SA
J Thromb Haemost; 2003 Jan; 1(1):164-70. PubMed ID: 12871554
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells.
Cao DJ; Guo YL; Colman RW
Circ Res; 2004 May; 94(9):1227-34. PubMed ID: 15044324
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis by a monoclonal antibody to kininogen as well as by kininostatin which block proangiogenic high molecular weight kininogen.
Colman RW
Int Immunopharmacol; 2002 Dec; 2(13-14):1887-94. PubMed ID: 12489802
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinases.
Liu Y; Sainz IM; Wu Y; Pixley R; Espinola RG; Hassan S; Khan MM; Colman RW
Exp Cell Res; 2008 Feb; 314(4):774-88. PubMed ID: 18062965
[TBL] [Abstract][Full Text] [Related]
15. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions.
Chavakis T; Kanse SM; Lupu F; Hammes HP; Müller-Esterl W; Pixley RA; Colman RW; Preissner KT
Blood; 2000 Jul; 96(2):514-22. PubMed ID: 10887113
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogen.
Chavakis T; Boeckel N; Santoso S; Voss R; Isordia-Salas I; Pixley RA; Morgenstern E; Colman RW; Preissner KT
J Biol Chem; 2002 Jun; 277(26):23157-64. PubMed ID: 11970955
[TBL] [Abstract][Full Text] [Related]
17. Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
Juarez JC; Guan X; Shipulina NV; Plunkett ML; Parry GC; Shaw DE; Zhang JC; Rabbani SA; McCrae KR; Mazar AP; Morgan WT; Doñate F
Cancer Res; 2002 Sep; 62(18):5344-50. PubMed ID: 12235005
[TBL] [Abstract][Full Text] [Related]
18. Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off.
Guo YL; Colman RW
J Thromb Haemost; 2005 Apr; 3(4):670-6. PubMed ID: 15733059
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties.
Al-Fakhri N; Chavakis T; Schmidt-Wöll T; Huang B; Cherian SM; Bobryshev YV; Lord RS; Katz N; Preissner KT
Biol Chem; 2003 Mar; 384(3):423-35. PubMed ID: 12715893
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo.
Hassan S; Sainz IM; Khan MM; Bradford HN; Isordia-Salas I; Kashem SW; Sartor RB; Colman RW
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2959-65. PubMed ID: 17293494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
